Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $50M Series D April 2023 bringing total to $147M; 160% net revenue retention
Honeycomb is a modern observability platform that helps engineering teams understand complex distributed systems through real-time data exploration and debugging capabilities. The company serves DevOps engineers, SREs, and software developers who need to troubleshoot production issues, optimize performance, and understand system behavior in microservices and cloud-native architectures. Honeycomb differentiates itself through high-cardinality data analysis, collaborative debugging workflows, and the ability to ask arbitrary questions of production data without pre-defining metrics, enabling teams to quickly identify and resolve issues in modern software systems.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.